Bone Metastases
📧 Sign up to get email alerts when something new happens for Bone Metastases.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer [Phase 2]
A Phase 2 trial evaluated zoledronic acid (Zometa) for bone metastases in lung cancer (including non-small cell and small cell) and was term…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Multicenter Study of Magnetic Resonance-guided High Intensity Focused Ultrasound for Pain Palliation of Bone Metastases [NA]
A multicenter trial evaluating MR-guided high-intensity focused ultrasound for pain palliation in bone metastases has been terminated. The s…
-
CLINICAL_TRIALS research · 2017-03-22Clinical Trial Update: A Safety Evaluation of MR-guided Focused Ultrasound Treatment for Palliative Pain Control of Bone Metastases [Phase 4]
Phase 4 clinical trial update evaluating the safety of magnetic resonance-guided focused ultrasound for palliative pain relief in bone metas…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Pilot Project: Fast Whole-body Spect Scanning to Improve the Detection of Bone Metastases in Patients With Diagnosed Cancer
A pilot trial evaluating fast whole-body SPECT imaging to improve detection of bone metastases in cancer patients has completed. The study w…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases [Phase 4]
This Phase 4 trial provides long-term efficacy and safety data for zoledronic acid in patients with bone metastases. The results help charac…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases [Phase 4]
Open-label Phase IV trial assessing the safety and tolerability of zoledronic acid in men with prostate cancer and bone metastases has compl…
-
CLINICAL_TRIALS withdrawal · 2017-02-07Clinical Trial Update: MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases [Phase 2]
Phase 2 trial of MRI-guided High Intensity Focused Ultrasound (HIFU) with ThermoDox for palliation of painful bone metastases has been withd…
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: The STAR Prospective Clinical Series
A completed STAR prospective clinical series sponsored by DFINE Inc to investigate metastasis to the vertebral column; no results are provid…
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: Evaluating Clinical Outcomes of Targeted Radiofrequency Ablation and Kyphoplasty (Also Known as Vertebral Augmentation) to Treat Painful Metastatic Vertebral Body Tumors [NA]
The trial evaluating targeted radiofrequency ablation with kyphoplasty for painful metastatic vertebral body tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: Phase Ib Study of Radium Ra 223 Dichloride in Combination With Paclitaxel in Cancer Subjects With Bone Lesions [Phase 1]
Phase Ib study of Radium-223 dichloride in combination with Paclitaxel for cancers with bone lesions has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis [Phase 4]
Phase 4 clinical trial evaluating zoledronic acid in patients with renal cell carcinoma and bone metastases has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-16Clinical Trial Update: Dexamethasone for Pain Flare After Radiotherapy of Painful Bone metastasesZonMW 11510009 [Phase 3]
Phase 3 trial assessing dexamethasone to prevent pain flares after radiotherapy in patients with painful bone metastases has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: Prospective Study Determining the Pain Response, Functional Interference and Quality of Life in Patients Undergoing Radiofrequency Ablation Assisted Vertebroplasty/ Cementoplasty
A prospective study evaluating pain response, functional interference, and quality of life in patients with neoplasms treated with radiofreq…
-
CLINICAL_TRIALS trial_result · 2016-08-29Clinical Trial Update: Randomized Study of Stereotactic Body Radiotherapy vs. Conventional Radiation for Spine Metastasis [Phase 2]
A randomized phase 2 trial comparing stereotactic body radiotherapy versus conventional radiation for spine metastases was terminated, with …
-
CLINICAL_TRIALS trial_result · 2016-08-25Clinical Trial Update: A Study to Compare Denosumab With Zoledronic Acid in Subjects With Bone Metastases From Solid Tumors [Phase 3]
A Phase 3 study comparing denosumab with zoledronic acid in patients with bone metastases has completed and results have been posted.
-
FDA approval · 2016-08-05FDA Approved: PROLIA — Supplemental Application (Amgen, Inc)
The FDA approved a supplemental application for PROLIA (denosumab) submitted by Amgen, Inc., signaling an approved modification to its label…
-
CLINICAL_TRIALS trial_result · 2016-07-28Clinical Trial Update: Differentiated Resistance Training of the Paravertebral Muscles in Patients With Unstable Spinal Bone Metastasis Under Concomitant Radiotherapy [Phase 2]
Phase 2 clinical trial evaluating differentiated resistance training of the paravertebral muscles in patients with unstable spinal bone meta…
-
FDA approval · 2016-07-14FDA Approved: ZOLEDRONIC ACID — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for a generic zoledronic acid product from Heritage Pharmaceuticals (d/b/a Avet Pharmaceuticals)…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Intensity-modulated Radiotherapy With Integrated-boost in Patients With Spinal Bone Metastases [Phase 2]
Phase 2 clinical trial update of intensity-modulated radiotherapy with an integrated boost in patients with spinal bone metastases.
-
FDA approval · 2016-05-19FDA Approved: SODIUM FLUORIDE F 18 — Original Application (Kreitchman PET Center)
FDA approved the original application for Sodium Fluoride F-18 as a radiopharmaceutical for PET bone imaging.
-
FDA approval · 2016-03-25FDA Approved: ZOLEDRONIC ACID — Supplemental Application (Sagent Pharmaceuticals)
FDA approved a supplemental application for zoledronic acid filed by Sagent Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: A Study to Evaluate Renal Safety of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Disease Due to Breast Cancer [Phase 3]
Phase 3 trial assessing renal safety of intravenous ibandronate (Bondronat) in patients with metastatic bone disease due to breast cancer ha…
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 2100 Conformal Bone System [Phase 2]
This document notes the completion of a Phase 2 clinical trial evaluating focused ultrasound surgery with the ExAblate 2100 Conformal Bone S…
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: Bone Response in Metastatic Breast Cancer Involving Bones
This clinical trial update summarizes results from a completed study evaluating bone response in patients with metastatic breast cancer invo…
-
CLINICAL_TRIALS trial_result · 2015-11-24Clinical Trial Update: Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases [Phase 2]
A Phase 2 clinical trial evaluating Sm-EDTMP with autologous peripheral blood stem cell transplantation in breast cancer patients with bone-…